Libert C - Search Results

1

Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1.

Van Hauwermeiren F, Vandenbroucke RE, Libert C. Van Hauwermeiren F, et al. Among authors: libert c. Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):311-9. doi: 10.1016/j.cytogfr.2011.09.004. Epub 2011 Oct 1. Cytokine Growth Factor Rev. 2011. PMID: 21962830 Review.

2

Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.

Wielockx B, Hochepied T, Staelens J, Van Molle W, Brouckaert P, Libert C. Wielockx B, et al. Among authors: libert c. Cytokine. 2001 Jul 21;15(2):59-65. doi: 10.1006/cyto.2001.0912. Cytokine. 2001. PMID: 11500080

3

Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties.

Hochepied T, Berger FG, Baumann H, Libert C. Hochepied T, et al. Among authors: libert c. Cytokine Growth Factor Rev. 2003 Feb;14(1):25-34. doi: 10.1016/s1359-6101(02)00054-0. Cytokine Growth Factor Rev. 2003. PMID: 12485617 Review.

4

Bilirubin release induced by tumor necrosis factor in combination with galactosamine is toxic to mice.

Van Molle W, Libert C. Van Molle W, et al. Among authors: libert c. Cytokine. 2003 Aug 7;23(3):94-100. doi: 10.1016/s1043-4666(03)00203-5. Cytokine. 2003. PMID: 12906872

5

Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?

Wielockx B, Libert C, Wilson C. Wielockx B, et al. Among authors: libert c. Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):111-5. doi: 10.1016/j.cytogfr.2003.12.001. Cytokine Growth Factor Rev. 2004. PMID: 15110795 Review.

6

Matrix metalloproteinase-8: cleavage can be decisive.

Van Lint P, Libert C. Van Lint P, et al. Among authors: libert c. Cytokine Growth Factor Rev. 2006 Aug;17(4):217-23. doi: 10.1016/j.cytogfr.2006.04.001. Epub 2006 Jul 3. Cytokine Growth Factor Rev. 2006. PMID: 16820317 Review.

7

Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice.

Dejager L, Libert C. Dejager L, et al. Among authors: libert c. Cytokine. 2008 Apr;42(1):55-61. doi: 10.1016/j.cyto.2008.01.014. Epub 2008 Mar 10. Cytokine. 2008. PMID: 18331798

8

Type I interferon drives tumor necrosis factor-induced lethal shock.

Huys L, Van Hauwermeiren F, Dejager L, Dejonckheere E, Lienenklaus S, Weiss S, Leclercq G, Libert C. Huys L, et al. Among authors: libert c. J Exp Med. 2009 Aug 31;206(9):1873-82. doi: 10.1084/jem.20090213. Epub 2009 Aug 17. J Exp Med. 2009. PMID: 19687227 Free PMC article.

9

Crosstalk between TNF and glucocorticoid receptor signaling pathways.

Van Bogaert T, De Bosscher K, Libert C. Van Bogaert T, et al. Among authors: libert c. Cytokine Growth Factor Rev. 2010 Aug;21(4):275-86. doi: 10.1016/j.cytogfr.2010.04.003. Epub 2010 Apr 24. Cytokine Growth Factor Rev. 2010. PMID: 20456998 Review.

10

Introduction to the session "Mechanisms of Pathological and Therapeutic Effects of the TNF Family".

Libert C. Libert C. Adv Exp Med Biol. 2011;691:401-2. doi: 10.1007/978-1-4419-6612-4_41. Adv Exp Med Biol. 2011. PMID: 21153344 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters